長鴻高科(605008.SH):持股14%的君盛峯石擬減持不超1284.7608萬股
格隆匯11月11日丨長鴻高科(605008.SH)公佈,截止公吿披露日,公司股東深圳君盛峯石股權投資基金合夥企業(有限合夥)(“君盛峯石”)持有公司無限售條件流通股份8990.2071萬股,佔公司總股本的14%,上述股份為公司首次公開發行股票並上市前取得。
君盛峯石擬通過集中競價方式或大宗交易方式合計減持不超過1284.7608萬股。君盛峯石對公司發展前景持續看好,但君盛峯石為股權投資公司,出於自身資金需求等相關因素考慮,需對投資項目進行相應的安排,後續君盛峯石將會結合自身情況以及市場情況等因素決定如何實施股份減持計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.